4-{[3-(2-Chloro-ethyl)-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carbonyl]-amino}-isophthalamide

ID: ALA37881

PubChem CID: 10069812

Max Phase: Preclinical

Molecular Formula: C15H13ClN8O4

Molecular Weight: 404.77

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1ccc(NC(=O)c2ncn3c(=O)n(CCCl)nnc23)c(C(N)=O)c1

Standard InChI:  InChI=1S/C15H13ClN8O4/c16-3-4-24-15(28)23-6-19-10(13(23)21-22-24)14(27)20-9-2-1-7(11(17)25)5-8(9)12(18)26/h1-2,5-6H,3-4H2,(H2,17,25)(H2,18,26)(H,20,27)

Standard InChI Key:  SBZBUHMRZHMZSI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
    5.8417   -6.9875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8375   -6.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0542   -5.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5542   -5.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5542   -7.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2667   -6.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2667   -6.9875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5667   -6.5792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0625   -7.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9667   -3.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7917   -5.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7667   -4.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9875   -4.9625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7500   -3.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2042   -4.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3375   -2.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0542   -1.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5542   -8.2250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3417   -4.5167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3542   -3.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9792   -7.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0875   -5.0750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2417   -1.6292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1417   -2.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5542   -3.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5917   -1.1500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6917   -8.6417    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.9792   -8.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  2  1  0
  5  1  1  0
  6  7  1  0
  7  5  1  0
  8  9  2  0
  9  1  1  0
 10 12  1  0
 11  3  1  0
 12 13  1  0
 13 11  1  0
 14 10  2  0
 15 10  1  0
 16 24  2  0
 17 16  1  0
 18  5  2  0
 19 11  2  0
 20 12  2  0
 21  7  1  0
 22 15  2  0
 23 17  2  0
 24 20  1  0
 25 15  1  0
 26 17  1  0
 27 28  1  0
 28 21  1  0
  3  8  1  0
  6  4  2  0
 14 16  1  0
M  END

Associated Targets(non-human)

TLX-5 (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 404.77Molecular Weight (Monoisotopic): 404.0748AlogP: -1.03#Rotatable Bonds: 6
Polar Surface Area: 180.36Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.57CX Basic pKa: CX LogP: 0.97CX LogD: 0.97
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.44Np Likeness Score: -1.74

References

1. Clark AS, Deans B, Stevens MF, Tisdale MJ, Wheelhouse RT, Denny BJ, Hartley JA..  (1995)  Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.,  38  (9): [PMID:7739008] [10.1021/jm00009a010]

Source